These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Antibody Drug Conjugates of Near-Infrared Photoimmunotherapy (NIR-PIT) in Breast Cancers. Cui Y; Xu Y; Li Y; Sun Y; Hu J; Jia J; Li X Technol Cancer Res Treat; 2023; 22():15330338221145992. PubMed ID: 36734039 [TBL] [Abstract][Full Text] [Related]
24. Near-infrared photoimmunotherapy targeting PD-L1: Improved efficacy by preconditioning the tumor microenvironment. Inagaki FF; Kano M; Furusawa A; Kato T; Okada R; Fukushima H; Takao S; Okuyama S; Choyke PL; Kobayashi H Cancer Sci; 2024 Jul; 115(7):2396-2409. PubMed ID: 38671582 [TBL] [Abstract][Full Text] [Related]
25. Near-infrared photoimmunotherapy and anti-cancer immunity. Nakajima K; Ogawa M Int Immunol; 2024 Feb; 36(2):57-64. PubMed ID: 37843836 [TBL] [Abstract][Full Text] [Related]
37. Immunization of stromal cell targeting fibroblast activation protein providing immunotherapy to breast cancer mouse model. Meng M; Wang W; Yan J; Tan J; Liao L; Shi J; Wei C; Xie Y; Jin X; Yang L; Jin Q; Zhu H; Tan W; Yang F; Hou Z Tumour Biol; 2016 Aug; 37(8):10317-27. PubMed ID: 26842926 [TBL] [Abstract][Full Text] [Related]
38. Near infrared photoimmunotherapy with an anti-mesothelin antibody. Nagaya T; Nakamura Y; Sato K; Zhang YF; Ni M; Choyke PL; Ho M; Kobayashi H Oncotarget; 2016 Apr; 7(17):23361-9. PubMed ID: 26981775 [TBL] [Abstract][Full Text] [Related]